1. Home
  2. RETO vs CVKD Comparison

RETO vs CVKD Comparison

Compare RETO & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RETO
  • CVKD
  • Stock Information
  • Founded
  • RETO 1999
  • CVKD 2022
  • Country
  • RETO China
  • CVKD United States
  • Employees
  • RETO N/A
  • CVKD N/A
  • Industry
  • RETO Multi-Sector Companies
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • RETO Consumer Discretionary
  • CVKD Health Care
  • Exchange
  • RETO Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • RETO 24.7M
  • CVKD 29.5M
  • IPO Year
  • RETO 2017
  • CVKD 2023
  • Fundamental
  • Price
  • RETO $2.09
  • CVKD $10.49
  • Analyst Decision
  • RETO
  • CVKD Strong Buy
  • Analyst Count
  • RETO 0
  • CVKD 1
  • Target Price
  • RETO N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • RETO 41.2K
  • CVKD 23.5K
  • Earning Date
  • RETO 07-07-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • RETO N/A
  • CVKD N/A
  • EPS Growth
  • RETO N/A
  • CVKD N/A
  • EPS
  • RETO N/A
  • CVKD N/A
  • Revenue
  • RETO $1,828,976.00
  • CVKD N/A
  • Revenue This Year
  • RETO N/A
  • CVKD N/A
  • Revenue Next Year
  • RETO N/A
  • CVKD N/A
  • P/E Ratio
  • RETO N/A
  • CVKD N/A
  • Revenue Growth
  • RETO N/A
  • CVKD N/A
  • 52 Week Low
  • RETO $1.91
  • CVKD $5.70
  • 52 Week High
  • RETO $18.20
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • RETO 29.05
  • CVKD 24.53
  • Support Level
  • RETO $3.05
  • CVKD $10.00
  • Resistance Level
  • RETO $3.15
  • CVKD $13.30
  • Average True Range (ATR)
  • RETO 0.25
  • CVKD 0.89
  • MACD
  • RETO -0.07
  • CVKD -0.39
  • Stochastic Oscillator
  • RETO 31.45
  • CVKD 4.67

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: